Living with Wilson Ein Projekt von Betroffenen für Betroffene

← Zurück zu allen Antworten

Will My Insurance Cover Out-of-Province Wilson Disease Treatment Without a Referral?

In China's public insurance system, out-of-province reimbursement rates are lower without a formal referral, but the gap can often be bridged — here is how the system works and how to improve your chances.

Going out of your home province to see a Wilson disease specialist is often medically necessary, but China’s basic medical insurance (基本医疗保险) was designed with local care in mind. The short answer to whether you will be reimbursed without a formal referral: partially, but probably at a lower rate, and there are meaningful steps you can take to close that gap before you travel.1 This page explains how the system works, what a formal referral unlocks, and what to do if you are already mid-treatment at an out-of-province hospital without one.

How China’s out-of-province reimbursement works

China’s public medical insurance is administered at the city or provincial level. When you receive care in a different province, you are typically in one of two situations:

With a formal referral (转诊): Your local designated hospital (定点医院) has referred you to an out-of-province facility. Reimbursement rates in this case are usually close to — though not always identical to — what you would receive locally. This is the pathway the system is designed for.

Without a formal referral: You went directly to an out-of-province hospital. In this case, reimbursement still exists but is typically reduced — sometimes by 10–20 percentage points of the eligible amount — and administrative hurdles are higher. Some cities and provinces set specific caps for unreferred out-of-province care.2

The National Healthcare Security Administration (国家医疗保障局) has been expanding cross-province direct settlement (跨省直接结算) since 2021, meaning that an increasing number of hospitals in major cities can process your claim on the spot rather than requiring you to pay upfront and apply later — but this is still not universal, and the reimbursement rate depends on your home province’s policy.3

What a formal referral actually does

A formal referral letter from your local hospital or county-level health authority:

  • Establishes that the care is medically necessary and not available locally
  • Triggers the higher reimbursement tier in most provinces
  • Creates a documented record that simplifies appeals if a claim is disputed
  • In some provinces, qualifies you for advance payment arrangements so you do not need to pay the full bill out of pocket and wait for reimbursement

For Wilson disease specifically, the argument for medical necessity is strong: it is a rare disease (罕见病), specialist centres are concentrated in a handful of cities (Beijing, Shanghai, Guangzhou, Hefei), and the window of the country’s leading hospitals.

Getting a referral even after the fact

If you have already started treatment at an out-of-province hospital without a referral, you may still be able to obtain one retroactively for ongoing visits — this depends on your local insurer’s rules, but it is worth asking. The steps:

  1. Go back to your local designated hospital with documentation of your diagnosis (discharge summary, genetic test report, treating specialist’s letter).
  2. Ask the local physician to issue a 转诊证明 confirming that local facilities cannot provide the required specialist care for Wilson disease.
  3. Submit this to your local medical insurance office (医保局) before your next out-of-province visit, or as part of a reimbursement appeal for past expenses.

The key phrase to use with local physicians: “Wilson disease is classified as a national rare disease; appropriate specialist care is only available at [specific hospital].” Hospitals like Beijing Tiantan Hospital or the First Affiliated Hospital of Anhui Medical University (Hefei) are recognised nationally for Wilson disease expertise and are more likely to be accepted as justified referral destinations.4

Rare disease special policy channels

Since 2019, China has maintained an official rare disease list (罕见病目录) that includes Wilson disease (肝豆状核变性). Inclusion on this list carries specific implications:

  • Drug access: Some drugs for listed rare diseases receive preferential import and pricing treatment
  • Insurance coverage: Some provinces have supplementary rare disease insurance pools (罕见病专项补偿) that cover expenses beyond the standard basic insurance ceiling
  • Reduced cost-sharing: Several provinces have reduced the co-payment (自付比例) for rare disease patients specifically

It is worth calling your provincial medical insurance office directly and asking: “Wilson disease is on the national rare disease list — is there a special reimbursement policy for out-of-province care?” The answer varies significantly by province, and the staff who handle routine claims may not know — ask to speak with someone in the rare disease section if one exists.5

Practical checklist before your next out-of-province trip

Action Who to contact When
Obtain formal 转诊证明 Local designated hospital physician Before travel
Register for cross-province direct settlement Local medical insurance office (医保局) Before travel
Ask about rare disease supplementary coverage Provincial medical insurance rare disease desk Before travel
Bring all diagnosis documentation Your treating specialist Every visit
Keep all receipts and itemised bills Hospital cashier Every visit
File reimbursement within deadline Local medical insurance office Within 6 months of discharge typically

The deadline for filing reimbursement varies by city — check with your local 医保局, as missing it can forfeit your claim entirely.

If your insurer denies the claim

You have the right to appeal (申诉). The appeal process involves submitting:

  • The referral letter (if you have one)
  • Proof that no equivalent local specialist is available (a written statement from the local hospital is ideal)
  • All medical records from the out-of-province hospital
  • The itemised bill

Wilson disease’s status as a listed rare disease strengthens your appeal. If the denial is upheld, you can escalate to the municipal or provincial medical insurance supervision office.

See what-to-tell-doctor for guidance on how to communicate your diagnosis and needs clearly to physicians who may be less familiar with Wilson disease, including local doctors who need to write your referral letter.

A note on commercial supplementary insurance

If you or your employer has supplementary commercial insurance (商业补充医疗保险 or 百万医疗险), review the policy wording carefully. Many commercial policies do not require referrals and reimburse a broader set of out-of-province expenses, sometimes up to a high annual cap. These policies are worth checking before assuming you must navigate only the public insurance pathway.

This page provides general information about China’s medical insurance system as it relates to Wilson disease patients. Insurance rules change frequently and vary significantly by province and city. Verify the current rules with your local 医保局 and, if needed, a healthcare administrator at your treating hospital before making travel or financial decisions.

References


  1. Zhou, Zhi-Hua, Yun-Fan Wu, Yan Yan, et al. “Persistence with Medical Treatment for Wilson Disease in China Based on a Single Center’s Survey Research.” Brain and Behavior 11, no. 6 (2021): e02168. https://doi.org/10.1002/brb3.2168. 

  2. Czlonkowska, Anna, et al. “Wilson Disease.” Nature Reviews Disease Primers 4, no. 1 (2018): 21. https://doi.org/10.1038/s41572-018-0024-5. 

  3. Alkhouri, Naim, Regino P. Gonzalez-Peralta, and Valentina Medici. “Wilson Disease: A Summary of the Updated AASLD Practice Guidance.” Hepatology Communications 7, no. 5 (2023): e0150. https://doi.org/10.1097/HC9.0000000000000150. 

  4. Schilsky, Michael L., Eve A. Roberts, Jeff M. Bronstein, et al. “A Multidisciplinary Approach to the Diagnosis and Management of Wilson Disease: 2022 Practice Guidance on Wilson Disease from the American Association for the Study of Liver Diseases.” Hepatology 82, no. 3 (2025): E41–E90. https://doi.org/10.1002/hep.32801. 

  5. European Association for the Study of the Liver. “EASL Clinical Practice Guidelines: Wilson’s Disease.” Journal of Hepatology 56, no. 3 (2012): 671–685. https://doi.org/10.1016/j.jhep.2011.11.007. 

  6. Weiss, Karl Heinz, et al. “Long Term Outcomes of Treatment with Trientine in Wilson Disease: Final Results from a Multicentre Study in Patients Withdrawn from D-Penicillamine Therapy.” Journal of Hepatology (2018). https://doi.org/10.1016/s0168-8278(18)30431-8. 

  7. Lee, Eun Joo, Min Hyung Woo, Jin Soo Moon, and Jae Sung Ko. “Efficacy and Safety of D-Penicillamine, Trientine, and Zinc in Pediatric Wilson Disease Patients.” Orphanet Journal of Rare Diseases 19, no. 1 (2024): 261. https://doi.org/10.1186/s13023-024-03271-1. 

Dies ist Patientenaufklärung, keine medizinische Beratung. Besprich Entscheidungen zu deiner Behandlung immer mit deinem eigenen medizinischen Team.